Cancer is tough for anyone who experiences it and for many people they are left fighting for there lives. Many health experts are endeavoring to discover an effective treatment for cancer that isn’t as devastating as radiation and chemo.Perhaps one of the most known is vitamin B17.
The History of Vitamin B17
America’s war on cancer was in full swing in the 70’s with Sloan-Kettering at the helm of one of the country’s leading cancer research centers. Ralph Moss joined the center ’74, when they were testing Laetrile – a form of vitamin B17.
It was the first bug job for Moss, and he was right in the thick of a potentially groundbreaking discovery.The tides quickly turner as Sloan-Kettering’s Board of Directors learned more. Laetrile was swept under the rug, and the research was put aside, Laetrile was determined to be potentially harmful.
Moss couldn’t sit on his laurels. What he saw as B17’s potential. He held a press conference on his own and accused his employer of orchestrating a major coverup of B17 research.
Laetrile has since been banned in the United States.
Why The Ban?
According to the FDA, B17 is highly toxic. However other physicians still disagree. In his book World Without Cancer, G. Edward Griffin – who has studied B17 extensively – says:“I have found no statements of demonstrated pharmacological harmfulness of amygdalin to human beings at any dosages recommended or employed by medical doctors in the United States and abroad.”
The Research Continues
Even though vitamin B17 has been banned and condemned as toxic in the U.S., researchers from around the world have continued to find positive results in clinical studies.In 2003, researchers found amygdalin from peach pits to have an influence on tumor growth.
In 2006, it was found to induce apoptosis by regulating Bax and Bcl-2 expressions in cancer cells.In 2013, it was found to be a potentially effective means of treating cervical cancer.In 2014, researchers found it to influence bladder cancer tumors.
You can see the obvious potential for Vitamin B17. Time and time again it showing positive results in a lab setting and surely its only a matter of time before it is reclassified and further research is carried out on its ground breaking possibilities.